Maria Grazia Maratta

Out in @FrontiersIn our experience in combined treatment for oligometastatic gastric cancer! Thanks to @MGMaratta @CarmeloPozzo and other colleagues! frontiersin.org/journals/oncol…

NETs are more common than you think. In prevalence they are more common than pancreatic cancer and patients with myeloma in the population. ☑️We help clinicians to keep NETs on their radar with #NETInfo in 11 languages: incalliance.org/net-info-packs/ #LetsTalkAboutNETs #MedTwitter

Pancreatic NET is among the most common NETs. #Gastroenterologists can be misled by common gastric symptoms. ✅Let’s support doctors with a snapshot of 26 types of NETs in 11 languages: incalliance.org/net-info-packs/ #LetsTalkAboutNETs #GITwitter #PancreasTwitter

A retrospective analysis on #PRRT for #NET reveals extending treatment beyond the standard 4 cycles may offer a safe & effective strategy. 📊 More cycles linked to better overall survival (72.8 months vs. 52.8 months) & disease-specific survival. #MedEd ow.ly/Ll4o50QgiPX

🦓Today is #NETCancerDay! Today we unite in one global voice to speak about neuroendocrine cancer and call for more NET awareness among HCPs, which will help them suspect it and diagnose it early. 📢Share our messages in 11 languages: incalliance.org/ncd-2023/ #LetsTalkAboutNETs

🦓Get ready: In 1 hour we start the ENETS-INCA #NETCancerDay Educational Webinar for patients and their families! Tune in from 12:00 to 14:15 CET on the ENETS website: enets.org/net-cancer-awa… #LetsTalkAboutNETs

Gemelli Rome Oncology Team at #ESMO23 in Madrid #ESMO #Gemelli

1st ASCO-AIOM clinical research course: glad to have been part of this!🩺💊🔬 Thanks to the faculty and to @AIOMtweet @ASCO instagram.com/p/CqgGjAtI4iJ/…

Neuroendocrine cancer is underrecognized. It often has very common symptoms and could be misdiagnosed as IBS, anxiety and asthma. 👉We need to place it on the diagnostic maps of HCPs. ✅Download #NETInfo in your language: bit.ly/3Zhi8rf #LetsTalkAboutNETs #GITwitter

Three incredible days in #Vienna for the 20th Annual #ENETS23 Conference. Such a great opportunity for #NETworking and #research. United to reflect on the main strategies to improving #patientcare 👨🏼‍🔬👩🏻‍⚕️♥️🦓 @netcancerday @CureNETs #ENETS

INCA/ENETS Symposium- @sugandhadureja shares an overview of the soon to be released“Think NENs” Educational Program for PCPs, available online in 5 languages. Engaging & educating PCPs is critical to improving diagnosis, treatment &access to care. @LACNETS @netcancerday @CureNETs

🚨NOW ONLINE🚨our last work: #Radiomcs to predict #immunotherapy efficacy in advanced #renalcellcarcinoma: a retrospective study 📲💻👩🏻‍💻 tandfonline.com/doi/full/10.10…

Updated📢 Management of toxicities from #immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment & follow-up. W/ recommended assessment & tx algorithms according to grade of toxicity ow.ly/K5nw50LcQyE @HaanenJohn @wick_wolfgang @peters_solange @MarieKostine

Cardiovascular complications of immune checkpoint inhibitors for cancer #Oncocardiology #Cardiooncology @escardio @myESMO @ASCO @OncoAlert @sitcancer @American_Heart academic.oup.com/eurheartj/adva…

❗️Negative results from #CheckMate914 Trial 🫠🥲🤦🏻‍♀️ Possible reason….🤷🏻‍♀️❓ - Not all anti PD1 are the same? (Nivo < Pembro) - M1 pts in KN564 vs only M0 in CM914? 🧐 Many other trials ongoing in #adjuvant #RCC… waiting for more data and more details!

Happy to share our review: Medullary Thyroid Cancer with Ectopic Cushing's Syndrome: A Case Report and Systematic Review of Detailed Cases from the Literature | Thyroid liebertpub.com/doi/10.1089/th… @DianaEstherossi @thyroidjournal 🎯Key points summarized below

📣 in press: our review on #PARPi/ICI combo in #ovarian cancer 📣 will preclinical rationale and early clinical data translate into meaningful benefit? 4 trials results are awaited ⏰ @lucia_musacchio @FlorianaCamarda @ketta_lorusso @ESMO_Open @myESMO esmoopen.com/article/S2059-…

There we are! So glad @myESMO managed to re-arrange this #meeting after cancellation due to #Covid-19 last December. Thank you all! @AlbigesL @ViktorGruenwald @crisuarez08 @tompowles1 @CPRT65 @MRoupret @y_loriot

@ViktorGruenwald kicking off @myESMO Preceptorship on Metastatic Urothelial Carcinoma and Kidney Cancer - Faculty @crisuarez08 @tompowles1 @CPRT65 @MRoupret @y_loriot, ABex, M Schmidinger, M De Santis, H Moch, G Von Amsberg line up for an intensive in person 2 days course !

La campagna #dirittoalloblio non si ferma. Partecipa anche tu e firma per dire no alla discriminazione degli ex pazienti oncologici: dirittoallobliotumori.org/cosa-fare/racc… #iononsonoilmiotumore #tunonseiltuotumore #fondazioneaiom #AIOM